This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thauvin, C
Right arrow Articles by Moellering, R C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thauvin, C
Right arrow Articles by Moellering, R C, Jr

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 February; 31(2): 139-143

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

C Thauvin, G M Eliopoulos, S Willey, C Wennersten and R C Moellering Jr

ABSTRACT

Intermittent administration of ampicillin alone has resulted in high failure rates in previously described animal models of enterococcal endocarditis. We developed a rat model of enterococcal endocarditis which permits comparison of continuous intravenous infusion of ampicillin with intramuscular therapy. Continuous low-dose ampicillin infusion (450 mg/kg [body weight] per day) was compared with the same dose given intramuscularly in three divided doses and with high-dose infusion (4.5 g/kg per day) of the drug. For the infecting strain of Streptococcus faecalis, the MIC and MBC were 1 microgram/ml. Mean ampicillin levels in serum were 53.9 +/- 4.8 (peak) and less than 1 (trough), 8.7 +/- 1.4, and 244 +/- 29 micrograms/ml for intramuscular, low-dose, and high-dose regimens, respectively. Ampicillin infusion therapy significantly increased the survival rate and sterilization of blood cultures. Continuous infusions were superior to intermittent therapy in eradicating bacteremia. After 5 days of treatment, low-dose ampicillin infusion was more effective than intermittent therapy in sterilizing cardiac vegetations (P less than 0.01). Continuous-infusion therapy at either dose was significantly more effective than intramuscular injection in reducing bacterial titers in cardiac vegetations (5.4 +/- 1.0 log10 CFU/g [low dose], 4.8 +/- 0.3 log10 CFU/g [high dose], and 7.7 +/- 0.3 log10 CFU/g [intramuscular]). However, no statistically significant advantage was found for high-dose compared with low-dose ampicillin infusion in lowering bacterial titers in vegetations (P greater than 0.3).

Antimicrob Agents Chemother. 1987 February; 31(2): 139-143




This article has been cited by other articles:

  • Lau, W. K., Mercer, D., Itani, K. M., Nicolau, D. P., Kuti, J. L., Mansfield, D., Dana, A. (2006). Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection. Antimicrob. Agents Chemother. 50: 3556-3561 [Abstract] [Full Text]  
  • DeRyke, C. A., Kuti, J. L., Mansfield, D., Dana, A., Nicolau, D. P. (2006). Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection. Am J Health Syst Pharm 63: 750-755 [Full Text]  
  • Berkhout, J., Visser, L. G., van den Broek, P. J., van de Klundert, J. A. M., Mattie, H. (2003). Clinical Pharmacokinetics of Cefamandole and Ceftazidime Administered by Continuous Intravenous Infusion. Antimicrob. Agents Chemother. 47: 1862-1866 [Abstract] [Full Text]  
  • Sakoulas, G., Eliopoulos, G. M., Alder, J., Eliopoulos, C. T. (2003). Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcusaureus. Antimicrob. Agents Chemother. 47: 1714-1718 [Abstract] [Full Text]  
  • Boucher, H. W., Thauvin-Eliopoulos, C., Loebenberg, D., Eliopoulos, G. M. (2001). In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis. Antimicrob. Agents Chemother. 45: 208-211 [Abstract] [Full Text]  
  • Cetinkaya, Y., Falk, P., Mayhall, C. G. (2000). Vancomycin-Resistant Enterococci. Clin. Microbiol. Rev. 13: 686-707 [Abstract] [Full Text]  
  • Souli, M., Thauvin-Eliopoulos, C., Eliopoulos, G. M. (2000). In Vivo Activities of Evernimicin (SCH 27899) against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci in Experimental Endocarditis. Antimicrob. Agents Chemother. 44: 2733-2739 [Abstract] [Full Text]  
  • Schülin, T., Thauvin-Eliopoulos, C., Moellering, R. C. Jr., Eliopoulos, G. M. (1999). Activities of the Oxazolidinones Linezolid and Eperezolid in Experimental Intra-Abdominal Abscess Due to Enterococcus faecalis or Vancomycin-Resistant Enterococcus faecium. Antimicrob. Agents Chemother. 43: 2873-2876 [Abstract] [Full Text]  
  • Gavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., Pigrau, C., Baquero, F., Pahissa, A. (1999). Efficacy of Ampicillin plus Ceftriaxone in Treatment of Experimental Endocarditis Due to Enterococcus faecalis Strains Highly Resistant to Aminoglycosides. Antimicrob. Agents Chemother. 43: 639-646 [Abstract] [Full Text]  
  • Leder, K., Turnidge, J. D., Korman, T. M ., Grayson, M. L. (1999). The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother 43: 113-118 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»